avalglucosidase alfa-ngpt 100 MG Injection
- RxCUI
- 2565818
- RxNorm name
- avalglucosidase alfa-ngpt 100 MG Injection
- Display name
- avalglucosidase alfa-ngpt 100 MG Injection
- Full name
- avalglucosidase alfa-ngpt 100 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761194 | Nexviazyme | avalglucosidase alfa-ngpt | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nexviazyme | AVALGLUCOSIDASE ALFA-NGPT | Genzyme Corporation | 80eb3c9c-01d3-44fe-90ef-81df101b954d | 2025-06-05 | Boxed warning, Warnings, Adverse reactions | 2565818 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 80eb3c9c-01d3-44fe-90ef-81df101b954d | avalglucosidase alfa-ngpt 100 MG Injection [PSN] · avalglucosidase alfa-ngpt 100 MG Injection [SCD] | 2 | 4 | These highlights do not include all the information needed to use NEXVIAZYME ® safely and effectively. See full prescribing information for NEXVIAZYME. NEXVIAZYME (avalglucosidase alfa-ngpt) for injection, for intravenous use Initial U.S. Approval: 2021 | 20250605 |